Search Results - "Lebleu, B."

Refine Results
  1. 1

    Cell-penetrating-peptide-based delivery of oligonucleotides: an overview by Abes, R, Arzumanov, A A, Moulton, H M, Abes, S, Ivanova, G D, Iversen, P L, Gait, M J, Lebleu, B

    Published in Biochemical Society transactions (01-08-2007)
    “…Cationic CPPs (cell-penetrating peptides) have been used largely for intracellular delivery of low-molecular-mass drugs, biomolecules and particles. Most…”
    Get more information
    Journal Article
  2. 2

    TAT peptide internalization: seeking the mechanism of entry by Vivès, E, Richard, J-P, Rispal, C, Lebleu, B

    Published in Current protein & peptide science (01-04-2003)
    “…During the last decade several peptides have been extensively studied for their ability to translocate across the plasma membrane. These peptides have been…”
    Get more information
    Journal Article
  3. 3

    A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus by Vivès, Eric, Brodin, Priscille, Lebleu, Bernard

    Published in The Journal of biological chemistry (20-06-1997)
    “…Tat is an 86-amino acid protein involved in the replication of human immunodeficiency virus type 1 (HIV-1). Several studies have shown that exogenous Tat…”
    Get full text
    Journal Article
  4. 4

    Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo by Moulton, H M, Fletcher, S, Neuman, B W, McClorey, G, Stein, D A, Abes, S, Wilton, S D, Buchmeier, M J, Lebleu, B, Iversen, P L

    Published in Biochemical Society transactions (01-08-2007)
    “…The cellular uptake of PMOs (phosphorodiamidate morpholino oligomers) can be enhanced by their conjugation to arginine-rich CPPs (cell-penetrating peptides)…”
    Get more information
    Journal Article
  5. 5

    Delivery of steric block morpholino oligomers by (R-X-R)₄ peptides: structure-activity studies by Abes, Rachida, Moulton, Hong M, Clair, Philippe, Yang, Sung-Tae, Abes, Said, Melikov, Kamran, Prevot, Paul, Youngblood, Derek S, Iversen, Patrick L, Chernomordik, Leonid V, Lebleu, Bernard

    Published in Nucleic acids research (01-11-2008)
    “…Redirecting the splicing machinery through the hybridization of high affinity, RNase H- incompetent oligonucleotide analogs such as phosphoramidate morpholino…”
    Get full text
    Journal Article
  6. 6

    Cellular uptake and intracellular fate of antisense oligonucleotides by Akhtar, Saghir, Juliano, R.L.

    Published in Current opinion in molecular therapeutics (01-04-2003)
    “…Antisense oligonucleotides and short interfering RNAs are routinely used for gene function analysis and are being developed for clinical applications. The…”
    Get full text
    Book Review Journal Article
  7. 7

    Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides by Abes, S, Moulton, H, Turner, J, Clair, P, Richard, J P, Iversen, P, Gait, M J, Lebleu, B

    Published in Biochemical Society transactions (01-02-2007)
    “…CPPs (cell-penetrating peptides) have given rise to much interest for the delivery of biomolecules such as peptides, proteins or ONs (oligonucleotides). CPPs…”
    Get more information
    Journal Article
  8. 8

    Arginine-rich cell penetrating peptides: Design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides by Abes, R., Arzumanov, A., Moulton, H., Abes, S., Ivanova, G., Gait, M. J., Iversen, P., Lebleu, B.

    Published in Journal of peptide science (01-04-2008)
    “…Rerouting the splicing machinery with steric‐block oligonucleotides (ON) might lead to new therapeutic strategies in the treatment of diseases such as…”
    Get full text
    Journal Article
  9. 9

    Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range by Meryet-Figuières, M., Resina, S., Lavigne, C., Barlovatz-Meimon, G., Lebleu, B., Thierry, A.R.

    Published in Biochimie (01-10-2007)
    “…Plasminogen activator inhibitor type I (PAI-1) plays a central role in metastatic behavior by increasing cells' migratory capacities as shown in several…”
    Get full text
    Journal Article
  10. 10

    Different mechanisms for cellular internalization of the HIV‐1 Tat‐derived cell penetrating peptide and recombinant proteins
fused to Tat by Silhol, Michelle, Tyagi, Mudit, Giacca, Mauro, Lebleu, Bernard, Vivès, Eric

    Published in European Journal of Biochemistry (01-01-2002)
    “…Translocation through the plasma membrane is a major limiting step for the cellular delivery of macromolecules. A␣promising strategy to overcome this problem…”
    Get full text
    Journal Article
  11. 11

    Intracellular Distribution of Microinjected Antisense Oligonucleotides by Leonetti, Jean Paul, Mechti, Nadir, Degols, Genevieve, Gagnor, Corinne, Lebleu, Bernard

    “…Antisense oligomers constitute an attractive class of specific tools for genetic analysis and for potential therapeutic applications. Targets with different…”
    Get full text
    Journal Article
  12. 12

    One-pot labeling and purification of peptides and proteins with fluorescein maleimide by Vivès, Eric, Lebleu, Bernard

    Published in Tetrahedron letters (14-07-2003)
    “…Fluorescein labeling of peptides and proteins is required for numerous biophysical or biological experiments such as fluorescence microscopy, fluorescence…”
    Get full text
    Journal Article
  13. 13

    Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide by Bongartz, J P, Aubertin, A M, Milhaud, P G, Lebleu, B

    Published in Nucleic acids research (11-11-1994)
    “…Recently several groups reported a dramatic improvement of reporter gene transfection efficiency using a fusogenic peptide, derived from the Influenza…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Selective coupling of a highly basic peptide to an oligonucleotide by Vivès, Eric, Lebleu, Bernard

    Published in Tetrahedron letters (17-02-1997)
    “…A highly basic peptide (net charge +8) derived from the HIV-1 Tat protein is conjugated with quantitative yield within minutes to a 19 mer rhodamine-labelled…”
    Get full text
    Journal Article
  16. 16

    Specific Antiviral Activity of a Poly(L-lysine)-Conjugated Oligodeoxyribonucleotide Sequence Complementary to Vesicular Stomatitis Virus N Protein mRNA Initiation Site by Lemaitre, Marc, Bayard, Bernard, Lebleu, Bernard

    “…Antisense oligonucleotides represent an interesting tool for selective inhibition of gene expression, but their efficient introduction within intact cells…”
    Get full text
    Journal Article
  17. 17

    Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes by Laktionov, Pavel P., Dazard, Jean-Eudes, Vives, Eric, Rykova, Elena Y., Piette, Jacques, Vlassov, Valentin V., Lebleu, Bernard

    Published in Nucleic acids research (01-06-1999)
    “…Inadequate cellular compartmentalisation of plasmid DNA and antisense oligodeoxynucleotides (ODNs) is generally considered as a major limitation in their use…”
    Get full text
    Journal Article
  18. 18

    Tat peptide-mediated cellular delivery: back to basics by Brooks, Hilary, Lebleu, Bernard, Vivès, Eric

    Published in Advanced drug delivery reviews (28-02-2005)
    “…Peptides are emerging as attractive drug delivery tools. The HIV Tat-derived peptide is a small basic peptide that has been successfully shown to deliver a…”
    Get full text
    Journal Article
  19. 19

    Comparative evaluation of seven oligonucleotide analogs as potential antisense agents by Morvan, F, Porumb, H, Degols, G, Lefebvre, I, Pompon, A, Sproat, B. S, Rayner, B, Malvy, C, Lebleu, B, Imbach, J. L

    Published in Journal of medicinal chemistry (1993)
    “…12-Mer analogues, representative of seven different classes of structurally modified oligonucleotides and complementary to the same target, have been compared…”
    Get full text
    Journal Article
  20. 20